A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis

Register your specific details and specific drugs of interest and we will match the information you provide to articles from our extensive database and email PDF copies to you promptly.

Learn more

Social Media

Back to Journals » Risk Management and Healthcare Policy » Volume 17

My Dovepress

Original Research

A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis

Total article views		HTML views	PDF downloads	Totals
1,271	Dovepress*	1,271+	17	1,288
1,271	Totals	1,271	17	1,288
*Since 13 April 2024

View citations on PubMed Central and Google Scholar